What the Democrats Are Doing Right Now Won't Lower Health Care Costs—but Here's What Actually Would
Four ideas that are better than extending Obamacare subsidies and a government shutdown.
Four ideas that are better than extending Obamacare subsidies and a government shutdown.
The fight over whether to extend "temporary" health insurance subsidies is really a fight over how best to hide the costs created by the Affordable Care Act.
Reason's Peter Suderman and Eric Boehm discuss the government shutdown live at 3 p.m. Eastern time today.
As ever, be cautious about what you hear from the Department of Health and Human Services.
Department of Veterans Affairs
What began as a simple hospital project has become yet another example of bureaucratic failure at the Department of Veterans Affairs
The expenditures are often costly privileges for special interests that mask the true size of government and fail to deliver the promised bang for the buck.
Many people prefer naturally produced over man-made. But isn't there something just as compelling about the stuff that thousands of people collaborated to make?
Texas Rep. Chip Roy joins Nick Gillespie to talk about runaway spending, the uphill battle for health care reform, and where immigration fits into the liberty vs. sovereignty debate.
The appeals court held that the government may require COVID-19 shots based purely on the benefits to recipients.
Plus: regulating college sports, forgiving baseball’s legends, and Happy Gilmore 2
Federal liability protections currently prevent people suing COVID-19 vaccine makers, and instead require them to request compensation from a program that's covered only 39 COVID vaccine injury claims.
Yale’s Jacob Hacker and Sesame’s David Goldhill debate a government-run health insurance plan.
Partisan pundits are misreading statistical estimates and misrepresenting the science to suggest that Trump's Medicaid cuts will kill 100,000 people. That claim doesn’t survive scrutiny.
Criminal justice reform advocates are still hopeful the office can secure outside funding and bring much-needed transparency to Arizona's prisons.
In a bill packed with spending, one provision offers real gains for health care choice and savings.
A more effective reform is to let the market curb waste and reward innovation.
First-place finishes include a piece on the Dutch "dropping" rite of passage, a documentary exploring citizen journalism and free speech, and a long-form interview with exoneree Amanda Knox.
Ailing Americans are winning expanded freedom to try experimental medicine.
Drugs like Ozempic might not only address obesity but also alcoholism, smoking, and drug addiction.
The executive order is likely unconstitutional, but if implemented as written, it would be detrimental to the American health care market.
Plus: A listener asks if the economic inequality data is bad.
The evolutionary biologist challenges modern dogmas, defends scientific objectivity, and warns against the rise of ideological orthodoxy in society.
Nominees include stories on inflation breaking brains, America's first drug war, Afghans the U.S. left behind, Javier Milei, and much more.
Plus: A listener asks which domestic policy changes could realistically boost U.S. manufacturing without raising costs for consumers.
A new study being used to call for mifepristone restrictions relies on vague and dubious definitions of drug-related complications.
John Arnold argues that private markets solve problems better than government or philanthropy, and that real reform comes from decentralization, incentives, and evidence—not top-down control.
These bills would require exactly that—and a lot more.
Longtime surgeon and Cato Institute fellow Jeffrey Singer argues that government overreach in health care undermines patient autonomy.
Former Obama administration economic adviser Jason Furman explains why both major parties have abandoned economic reality in favor of political fantasy.
While not as good as full legalization of organ markets, the act could save lives by giving kidney donors a $50,000 tax credit.
RFK Jr. should accept the ruling and instruct the agency to immediately halt all efforts to regulate laboratory-developed and in vitro tests.
The ballot proposition would effectively require health insurers to cover all treatments at any price.
Authors James Fadiman and Jordan Gruber discuss their new book Microdosing for Health, Healing, and Enhanced Performance.
Is shutting down the CDC's HIV prevention division a good idea?
Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.
Reform could replace an unsustainable boondoggle with lower costs, more freedom, and better care.
A popular narrative says Europeans are better off because of increased regulation. Reality paints a different picture.
Despite severe risks and without a crime committed, a Minnesota judge authorized doctors to forcibly administer electroconvulsive therapy—while barring key witnesses from the hearing.
Prosecutors claim the case is about coercion. So why isn’t that the charge they are bringing?
The bill would permanently schedule fentanyl-related substances as Schedule I drugs—and impede therapeutic research.
Two new meta-analyses make a case for individualistic approaches to puberty blockers and hormone treatments, driven by patients, parents, and doctors rather than the state.
Another significant administrative law grant of certiorari (and a dog that didn't bark).
Nick Flannery faces 12 years in prison for allegedly shaking his 2-month-old son. Child protective services are ignoring the other possible causes of his son's medical problem.
The case gives the Supreme Court an opportunity to revisit a widely reviled decision that invited such eminent domain abuses.